Literature DB >> 12819053

Control of the oxidative burst of human neutrophils by staphylococcal leukotoxins.

Didier A Colin1, Henri Monteil.   

Abstract

The ability of staphylococcal two-component leukotoxins to induce an oxidative burst and/or to prime human polymorphonuclear cells (PMNs) was studied by using spectrofluorometry or flow cytometry. At sublytic concentrations, the HlgA-HlgB, HlgA-LukF-PV, LukS-PV-LukF-PV, and HlgC-LukF-PV combinations of leukotoxins, but not the LukS-PV-HlgB and HlgC-HlgB combinations, were able to induce H(2)O(2) production similar to the H(2)O(2) production induced by 1 micro M N-formyl-Met-Leu-Phe (fMLP). In addition, when added at sublytic concentrations, all of the leukotoxin combinations primed PMNs for H(2)O(2) production induced by fMLP. Leukotoxin activation was dependent on the presence of Ca(2+) and was inhibited by wortmannin, an inhibitor of phosphatidylinositol 3-kinase, but not by N-methyl-L-arginine, an inhibitor of NO generation, which eliminates the possibility that NO plays a role in the action of leukotoxins. At higher concentrations, all leukotoxins inhibited H(2)O(2) production by PMNs activated by fMLP, phorbol 12-myristate 13-acetate (PMA), or the leukotoxins themselves. This inhibition was not related to the pore formation induced by leukotoxins. Intracellular release of H(2)O(2) induced by fMLP and PMA was not primed by leukotoxins but was inhibited. It seems that leukotoxin inhibition of H(2)O(2) release is independent of pore formation but secondary to an intracellular event, as yet unknown, triggered by leukotoxins.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12819053      PMCID: PMC161991          DOI: 10.1128/IAI.71.7.3724-3729.2003

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  31 in total

Review 1.  Staphylococcal pore-forming toxins.

Authors:  G Prévost; L Mourey; D A Colin; G Menestrina
Journal:  Curr Top Microbiol Immunol       Date:  2001       Impact factor: 4.291

2.  Improved purification of leukocidin from Staphylococcus aureus and toxin distribution among hospital strains.

Authors:  V Finck-Barbançon; G Prévost; Y Piémont
Journal:  Res Microbiol       Date:  1991-01       Impact factor: 3.992

3.  Pneumolysin, the thiol-activated toxin of Streptococcus pneumoniae, does not require a thiol group for in vitro activity.

Authors:  F K Saunders; T J Mitchell; J A Walker; P W Andrew; G J Boulnois
Journal:  Infect Immun       Date:  1989-08       Impact factor: 3.441

4.  Phorbol myristate acetate induces neutrophil NADPH-oxidase activity by two separate signal transduction pathways: dependent or independent of phosphatidylinositol 3-kinase.

Authors:  A Karlsson; J B Nixon; L C McPhail
Journal:  J Leukoc Biol       Date:  2000-03       Impact factor: 4.962

5.  Flow cytometric determination of Panton-Valentine leucocidin S component binding.

Authors:  V Gauduchon; S Werner; G Prévost; H Monteil; D A Colin
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

6.  Roles of phosphatidylinositol 3-kinase and phospholipase D in temporal activation of superoxide production in FMLP-stimulated human neutrophils.

Authors:  K Yasui; A Komiyama
Journal:  Cell Biochem Funct       Date:  2001-03       Impact factor: 3.685

7.  The onset of the respiratory burst in human neutrophils. Real-time studies of H2O2 formation reveal a rapid agonist-induced transduction process.

Authors:  M P Wymann; V von Tscharner; D A Deranleau; M Baggiolini
Journal:  J Biol Chem       Date:  1987-09-05       Impact factor: 5.157

8.  Discoupling the Ca(2+)-activation from the pore-forming function of the bi-component Panton-Valentine leucocidin in human PMNs.

Authors:  L Baba Moussa; S Werner; D A Colin; L Mourey; J D Pédelacq; J P Samama; A Sanni; H Monteil; G Prévost
Journal:  FEBS Lett       Date:  1999-11-19       Impact factor: 4.124

9.  Proinflammatory interactions of pneumolysin with human neutrophils.

Authors:  R Cockeran; A J Theron; H C Steel; N M Matlola; T J Mitchell; C Feldman; R Anderson
Journal:  J Infect Dis       Date:  2001-01-17       Impact factor: 5.226

10.  Superoxide generation by human neutrophils induced by low doses of Escherichia coli hemolysin.

Authors:  S Bhakdi; E Martin
Journal:  Infect Immun       Date:  1991-09       Impact factor: 3.441

View more
  20 in total

1.  Pro-inflammatory feedback activation cycle evoked by attack of Vibrio cholerae cytolysin on human neutrophil granulocytes.

Authors:  Angela Valeva; Ivan Walev; Silvia Weis; Fatima Boukhallouk; Trudy M Wassenaar; Sucharit Bhakdi
Journal:  Med Microbiol Immunol       Date:  2007-09-20       Impact factor: 3.402

2.  Sublytic concentrations of Staphylococcus aureus Panton-Valentine leukocidin alter human PMN gene expression and enhance bactericidal capacity.

Authors:  Shawna F Graves; Scott D Kobayashi; Kevin R Braughton; Adeline R Whitney; Daniel E Sturdevant; Devon L Rasmussen; Liliya N Kirpotina; Mark T Quinn; Frank R DeLeo
Journal:  J Leukoc Biol       Date:  2012-05-11       Impact factor: 4.962

3.  Analysis of the specificity of Panton-Valentine leucocidin and gamma-hemolysin F component binding.

Authors:  Florent Meyer; Raymonde Girardot; Yves Piémont; Gilles Prévost; Didier A Colin
Journal:  Infect Immun       Date:  2008-10-06       Impact factor: 3.441

Review 4.  Staphylococcus aureus pore-forming toxins: The interface of pathogen and host complexity.

Authors:  E Sachiko Seilie; Juliane Bubeck Wardenburg
Journal:  Semin Cell Dev Biol       Date:  2017-04-23       Impact factor: 7.727

Review 5.  The bicomponent pore-forming leucocidins of Staphylococcus aureus.

Authors:  Francis Alonzo; Victor J Torres
Journal:  Microbiol Mol Biol Rev       Date:  2014-06       Impact factor: 11.056

6.  Staphylococcus aureus leukotoxin GH promotes inflammation.

Authors:  Natalia Malachowa; Scott D Kobayashi; Kevin R Braughton; Adeline R Whitney; Michael J Parnell; Donald J Gardner; Frank R Deleo
Journal:  J Infect Dis       Date:  2012-08-07       Impact factor: 5.226

Review 7.  Mechanisms of bacterial virulence in pulmonary infections.

Authors:  Samuel M Moskowitz; Jeanine P Wiener-Kronish
Journal:  Curr Opin Crit Care       Date:  2010-02       Impact factor: 3.687

Review 8.  The rise and rise of Staphylococcus aureus: laughing in the face of granulocytes.

Authors:  S Anwar; L R Prince; S J Foster; M K B Whyte; I Sabroe
Journal:  Clin Exp Immunol       Date:  2009-08       Impact factor: 4.330

Review 9.  Waves of resistance: Staphylococcus aureus in the antibiotic era.

Authors:  Henry F Chambers; Frank R Deleo
Journal:  Nat Rev Microbiol       Date:  2009-09       Impact factor: 60.633

Review 10.  Reemergence of antibiotic-resistant Staphylococcus aureus in the genomics era.

Authors:  Frank R DeLeo; Henry F Chambers
Journal:  J Clin Invest       Date:  2009-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.